Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine (Q36681036)

15 August 2017

1 reference

title

Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine (English)

1 reference

15 August 2017

0 references

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

Anita De Rossi

3

0 references

Carlo Giaquinto

series ordinal

1

object named as

Carlo Giaquinto

1 reference

15 August 2017

Osvalda Rampon

2

1 reference

15 August 2017

1 January 2006

1 reference

Clinical Drug Investigation

15 August 2017

1 reference

15 August 2017

26

1 reference

15 August 2017

11

1 reference

15 August 2017

611-627

1 reference

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

15 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200626110-00001

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00044011-200626110-00001

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

21 January 2018

1 reference

12 December 2020

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

1 reference

12 December 2020

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?

1 reference

12 December 2020

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

12 December 2020

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades

1 reference

12 December 2020

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

1 reference

12 December 2020

Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation

1 reference

12 December 2020

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

1 reference

12 December 2020

Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine

1 reference

12 December 2020

Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.

1 reference

12 December 2020

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

1 reference

12 December 2020

Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy

1 reference

12 December 2020

Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.

1 reference

12 December 2020

Selective vertical transmission of HIV-1 antiretroviral resistance mutations

1 reference

12 December 2020

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

1 reference

12 December 2020

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

1 reference

12 December 2020

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study

1 reference

12 December 2020

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

12 December 2020

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

1 reference

12 December 2020

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

1 reference

12 December 2020

Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.

1 reference

12 December 2020

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial

1 reference

12 December 2020

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

12 December 2020

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

1 reference

12 December 2020

Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

1 reference

12 December 2020

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

1 reference

12 December 2020

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

12 December 2020

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Single-dose nevirapine and drug resistance: the more you look, the more you find

1 reference

12 December 2020

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

12 December 2020

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

1 reference

12 December 2020

Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.

1 reference

12 December 2020

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns

1 reference

12 December 2020

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

12 December 2020

Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission

1 reference

12 December 2020

Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.

1 reference

12 December 2020

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

12 December 2020

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

1 reference

12 December 2020

Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine

1 reference

12 December 2020

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

12 December 2020

Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission

1 reference

12 December 2020

Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance

1 reference

12 December 2020

Breast-feeding and Transmission of HIV-1.

1 reference

12 December 2020

10.2165/00044011-200626110-00001

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17163296